StreetAlpha.app
Home › Stocks › ZBH

Zimmer Biomet Holdings, Inc. (ZBH)

Healthcare
$102.11
▲ +0.67%
LAST CLOSE · NOV 17

Zimmer Biomet makes orthopedic implants, surgical products and robotic technologies for surgeons and hospitals worldwide. It last closed at $102.11 on Nov 17, up 0.67% on the day. ZBH reports earnings on Tue, Feb 9, 2027. The average 12-month price target from 10 analysts is $120.30 (+17.8% from the last close), with a high of $140.00 and a low of $101.00. Analyst consensus is Buy, based on the latest ratings from 10 firms (5 buy, 5 hold, 0 sell). In the past 30 days there were 7 dark pool prints totaling $7.6M, the largest $1.4M.

AI Auto Pilots
Is ZBH in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$8.6B
+7.0% vs a year ago
Net income
$767.4M
−4.7% vs a year ago
EPS (diluted)
$3.96
−1.7% vs a year ago
Free cash flow
$1.6B
19.2% margin
Valuation
Market cap
$19.3B
189.3M shares
P/E
25.8
Price over 12 month EPS
Price to sales
2.3
Market cap over revenue
Dividend yield
0.94%
$0.96 a share over 12 months
Balance sheet
Cash & equivalents
$399.9M
At Sep 30
Debt
$7.5B
At Sep 30
Shareholder equity
$12.7B
Buybacks
$829.3M
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $6.8B$6.8BFY2021FY2022: $6.9B$6.9BFY2022FY2023: $7.4B$7.4BFY2023FY2024: $7.7B$7.7BFY2024FY2025: $8.2B$8.2BFY2025

From ZBH's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 9
2027 · Time not announced
Consensus EPS forecast
$2.49
$2.29B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Buy
Based on 10 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
10firms
5 Buy5 Hold0 Sell
Each firm's latest rating on ZBH in the past 90 days
Average 12-month target
$120.30
▲ 17.8% upside

Based on 10 analysts who set a price target on ZBH in the past 90 days. The average target is $120.30, with a high of $140.00 and a low of $101.00, compared with the last close of $102.11.

Low $101.00Avg $120.30High $140.00
Blue marker: last close $102.11
Highest target$140.00
Average target$120.30
Lowest target$101.00
Latest rating changes
Wells FargoUpgrade
Nov 17Buy$113 → $123
BMO CapitalTarget raised
Nov 16Hold$95 → $101
StifelTarget raised
Nov 16Buy$110 → $140
BarclaysMaintained
Nov 9Hold$115
UBSTarget raised
Nov 6Buy$115 → $130
DateFirmActionRatingPrice target
Nov 17Wells FargoUpgradeBuy$113 → $123
Nov 16BMO CapitalTarget raisedHold$95 → $101
Nov 16StifelTarget raisedBuy$110 → $140
Nov 9BarclaysMaintainedHold$115
Nov 6UBSTarget raisedBuy$115 → $130
Loading…

Technical Analysis

ZBH · as of the Nov 17 close · updated after every close
Uptrend

The stock is 1% above its 20 day and 6% above its 50 day average. It is 9% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 54). The nearest support is the 20 day average at $101.28, and the nearest resistance the swing high (Aug 24) at $102.12.

Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 3.3%/day
Key levels
$112.5552 week high+10.2%
$103.78Pivot R1+1.6%
$102.61Pivot+0.5%
$102.12Swing high (Aug 24)+0.0%
$102.11Last close
$101.2820 day average−0.8%
$100.95Pivot S1−1.1%
$95.9950 day average−6.0%
$95.47100 day average−6.5%
$94.38Swing low (Oct 30)−7.6%
$92.68200 day average−9.2%
$79.1252 week low−22.5%
Indicators
RSI (14)53.58Middle of its rangeNeutral
MACD2.52Below its signal lineBearish
Stochastic43.3Middle of its rangeNeutral
ADX (14)24.7Weak trend
Williams %R-57.5Oversold below −80, overbought above −20Neutral
CCI (20)20.1Oversold below −100, overbought above 100Neutral
Rate of change+5.2%Change over 10 sessionsBullish
ATR (14)$3.34Typical daily range, 3.3% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for ZBH

What happened before

See how ZBH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow ZBH usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ZBH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in ZBH in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
7
Notional
$7.6M
Largest print
$1.4M
Loading…

ZBH Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●377 buying vs 392 selling
  • ▼Held by funds -7.0 pts
  • ▲Funds holding +15
  • ▼Superinvestors: 2 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding931916+1.6%
In funds' top 1068−25.0%
Held by funds98.3%105.3%−7.0 pts
New / increased105 / 27284 / 317−6.0%
Reduced / sold out318 / 74306 / 90−1.0%
Put/call ratio2.400.68+250.5%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ZBH institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

ZBH Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$829.3M
4.3% yield
Left in program
$924.7M
4.8% of value
Shares outstanding, 12 months
−4.5%
Fewer shares
Last quarter
$78.4M
Sep 2026
Avg price paid, last quarter
$95.54
821K shares bought
S&P 500 rank by spending
#219 of 358
 
Spent each quarter, last 3 yearsTop bar $596.6M
Dec 2023: $435.9M, average price $115.59Mar 2024: $88.0M, average price $121.72Jun 2024: $95.4M, average price $107.43Sep 2024: $596.6M, average price $109.10Dec 2024: $58.1M, average price $104.62Mar 2025: $229.8M, average price $106.36Jun 2025: $0Sep 2025: $0Dec 2025: $250.0M, average price $92.21Mar 2026: $250.0M, average price $95.52Jun 2026: $246.8M, average price $84.60Sep 2026: $78.4M, average price $95.54
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ZBH is in one of them and how their past ZBH trades turned out.

ZBH in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ZBH in an article yet. Here's the latest on the wider market.

ZBH Congress Trades

All congress trades →
Trades, 12 months
28
Buys
11
39%
Sells
17
61%
People
3
Last filed Nov 5
Who traded ZBH · since 2018
Latest 5 filings of 95
$1K – $15KTraded Oct 30, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 30, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 5, 2026Filed Nov 5, 2026
$1K – $15KTraded Sep 14, 2026Filed Oct 7, 2026
$1K – $15KTraded Sep 14, 2026Filed Oct 7, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CASell$1K – $15KOct 30, 2026Nov 5, 20266 d
Ro KhannaD · CASell$1K – $15KOct 30, 2026Nov 5, 20266 d
Ro KhannaD · CASell$1K – $15KOct 5, 2026Nov 5, 202631 d
Ro KhannaD · CASell$1K – $15KSep 14, 2026Oct 7, 202623 d
Ro KhannaD · CASell$1K – $15KSep 14, 2026Oct 7, 202623 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Zimmer Biomet Holdings

Zimmer Biomet makes medical devices used to treat disorders of, or injuries to, bones, joints and supporting soft tissues. Its product lines include knee and hip replacement implants, sports medicine and trauma products, craniomaxillofacial and chest products, bone cement, surgical products, and digital and robotic technologies. Its main customers are orthopedic surgeons, neurosurgeons, hospitals, ambulatory surgery centers and distributors, and it is based in Warsaw, Indiana.

Headquarters
Warsaw, IN
Founded
1927